KPJ Healthcare’s 4QFY23 net profit increased by 14% YoY to RM83.5m, mainly due to higher influx of patient volume and bed occupancy rate (BOR). After stripping off non-operating items, KPJ FY23 core net profit increased by 47% YoY to RM107.9m. The results were within our expectation but exceeded street’s estimates at 120% of full-year forecast. KPJ has completed the disposal on its loss-making Indonesian operation and aged care operation in Australia. For 1HFY24, we expect KPJ’s BOR to remain at c.70% backed by higher inpatient volume. We maintain our FY24-25F earnings forecasts and our Outperform rating with unchanged SOTP-based TP of RM1.81, based on 12x EV/EBITDA (near Malaysia hospital average). KPJ declared an interim dividend of 1.0 sen per share.
Source: PublicInvest Research - 19 Feb 2024
Chart | Stock Name | Last | Change | Volume |
---|
2024-12-19
KPJ2024-12-18
KPJ2024-12-17
KPJ2024-12-17
KPJ2024-12-17
KPJ2024-12-16
KPJ2024-12-16
KPJ2024-12-16
KPJ2024-12-16
KPJ2024-12-13
KPJ2024-12-13
KPJ2024-12-13
KPJ2024-12-13
KPJ2024-12-13
KPJ2024-12-12
KPJ2024-12-12
KPJ2024-12-12
KPJ2024-12-12
KPJ2024-12-12
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-10
KPJ2024-12-10
KPJ2024-12-10
KPJCreated by PublicInvest | Dec 19, 2024